Hugo Guillermo Ternavasio-de la Vega

Dr. Hugo Guillermo Ternavasio-de la Vega

M.D, PhD, Hospital Virgen de la Concha, Zamora, Spain
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2018 in Epidemiology and Infection
Verified
Journal Article
Closed access
PDF file
HVHugo Guillermo Ternavasio-de la Vega
Hugo Guillermo Ternavasio-de la Vega
FCF. Castaño-Romero
F. Castaño-Romero
SRS. Ragozzino
S. Ragozzino
RGR. Sánchez González
R. Sánchez González
MVM. P. Vaquero-Herrero
M. P. Vaquero-Herrero
MMMiguel Marcos
Miguel Marcos
The objective was to compare the performance of the updated Charlson comorbidity index (uCCI) and classical CCI (cCCI) in predicting 30-day mortality in patients with Staphylococcus aureus bacteraemia (SAB). All cases of SAB in patients aged ⩾14 years identified at the Microbiology Unit were included prospectively and followed. Comorbidity was evaluated using the cCCI and uCCI. Relevant variables associated with SAB-related mortality, along with cCCI or uCCI scores, were entered into multivariate logistic regression models. Global model fit, model calibration and predictive validity of each model were evaluated and compared. In total, 257 episodes of SAB in 239 patients were included (mean age 74 years; 65% were male). The mean cCCI and uCCI scores were 3.6 (standard deviation, 2.4) and 2.9 (2.3), respectively; 161 (63%) cases had cCCI score ⩾3 and 89 (35%) cases had uCCI score ⩾4. Sixty-five (25%) patients died within 30 days. The cCCI score was not related to mortality in any model, but uCCI score ⩾4 was an independent factor of 30-day mortality (odds ratio, 1.98; 95% confidence interval, 1.05–3.74). The uCCI is a more up-to-date, refined and parsimonious prognostic mortality score than the cCCI; it may thus serve better than the latter in the identification of patients with SAB with worse prognoses.

1 March 2010 in Medicine
Verified
Journal Article
Closed access
HVHugo Guillermo Ternavasio-de la Vega
Hugo Guillermo Ternavasio-de la Vega
MBMauro Boronat
Mauro Boronat
AOAntonio Ojeda
Antonio Ojeda
YGYaiza García-Delgado
Yaiza García-Delgado
AÁAlfonso Ángel-Moreno
Alfonso Ángel-Moreno
JPJosé-Luis Perez-Arellano
José-Luis Perez-Arellano
Since the introduction of the mumps vaccine, the age of appearance of mumps infection has shifted from children to adolescents and young adults, groups with a higher incidence of disease complications and sequelae. During the years 2000-2001, the Gran Canaria Island was part of an epidemic of mumps. In that period, our institution attended 67 cases of serologically confirmed acute mumps orchitis, the most serious complication of mumps infection in young postpubertal males. We conducted a descriptive and prospective study of this cohort and extensively reviewed the literature from 1967 (the year the first mumps vaccine was introduced) to 2009. Fifty-six patients were admitted because of general impairment and were treated with alpha-interferon. Sixty-six patients presented parotitis previous to orchitis (interval from parotitis to orchitis, 4.9 d). Orchitis was unilateral in 89.5% and bilateral in 10.4% of cases. More than 98% of patients had orchitis-associated fever. Nine patients had clinical and biochemical data showing acute mumps meningitis, and 11 had subclinical pancreatitis. The mean duration of symptoms was 4.6 days (range, 1-9). During the acute phase, more than 41% of the evaluated testes had a volume >25 mL. Acute hormonal disturbances were highly prevalent. These included decreased levels of testosterone and inhibin B with low or normal levels of gonadotropins in 35% of subjects, and, to our knowledge not previously reported, an atypical hormonal pattern consisting of low levels of free testosterone and inhibin B, along with increased measures of luteinizing hormone but low or normal follicle-stimulating hormone levels (11% of cases). During the follow-up period (mean, 331 d) a high incidence of sperm disturbance was found.

21 August 2017 in Mycoses
Verified
Journal Article
Closed access
PDF file
MVMaría Paz Vaquero‐Herrero
María Paz Vaquero‐Herrero
SRSilvio Ragozzino
Silvio Ragozzino
FCFabián Castaño‐Romero
Fabián Castaño‐Romero
MSMaría Siller‐Ruiz
María Siller‐Ruiz
RGRebeca Sánchez González
Rebeca Sánchez González
HVHugo Guillermo Ternavasio-de la Vega
Hugo Guillermo Ternavasio-de la Vega

1 April 2009 in Emerging Infectious Diseases
Verified
Journal Article
Open access
HVHugo Guillermo Ternavasio-de la Vega
Hugo Guillermo Ternavasio-de la Vega
AÁAlfonso Ángel-Moreno
Alfonso Ángel-Moreno
MHMichele Hernández-Cabrera
Michele Hernández-Cabrera
EPElena Pisos-Álamo
Elena Pisos-Álamo
MBMargarita Bolaños-Rivero
Margarita Bolaños-Rivero
JPJosé-Luis Perez-Arellano
José-Luis Perez-Arellano
An unusual skin and soft tissue infection of the lower limbs has been observed in immigrants from sub-Saharan Africa who cross the Atlantic Ocean crowded on small fishing boats (pateras). Response to conventional treatment is usually poor. Extreme extrinsic factors (including new pathogens) may contribute to the etiology of the infection and its pathogenesis.

25 April 2011 in Cytometry Part B: Clinical Cytometry
Verified
Journal Article
Open access
PDF file
HVHugo Guillermo Ternavasio-de la Vega
Hugo Guillermo Ternavasio-de la Vega
VVVirginia Velasco‐Tirado
Virginia Velasco‐Tirado
LPLaura Pozo‐Rosado
Laura Pozo‐Rosado
MSMaría‐Carmen Soler‐Fernández
María‐Carmen Soler‐Fernández
MPMartín Pérez-Andrés
Martín Pérez-Andrés
LGLuis González‐Villaron
Luis González‐Villaron
Analyzing the phenotypic characterization of the immune system cells involved in the pathogenesis of immunodeficiency with thymoma (Good's syndrome) is difficult due to the low number of studies on that subject. We describe the immunological alterations observed in a case of Good's syndrome, and we summarize the pathogenic explanations found in the literature. © 2011 International Clinical Cytometry Society

1 October 2016 in Journal of Hospital Infection
Verified
Journal Article
Closed access
HVHugo Guillermo Ternavasio-de la Vega
Hugo Guillermo Ternavasio-de la Vega
AVA. Barbosa Ventura
A. Barbosa Ventura
FCF. Castaño-Romero
F. Castaño-Romero
FSF.D. Sauchelli
F.D. Sauchelli
AAA. Prolo Acosta
A. Prolo Acosta
JLJ. Laso
J. Laso